Covid vaccine developer CureVac shores up C-suite as it heads toward IPO
August 04, 2020 at 13:41 PM EDT
The local drugmaker has firmed up its executive team, hiring a Novartis executive and finalizing its CEO pick in advance of its must-anticipated IPO.